Skip to Content

Aerovate Therapeutics Inc AVTE Stock Quote

| Rating as of


Last close prices updated as of Feb 06, 2023, 4:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 25
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style
  • Day Range 23.74  –  25.45
  • Year Range 8.33  –  30.79
  • Market Cap 615.1268 Mil
  • Volume / Avg 75,632.0 /  172,248.5
  • Price / Sales
  • Price / Book 4.42
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis AVTE

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics AVTE

Company Profile AVTE

Business Description

Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Its initial focus is on advancing AV-101, dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, a devastating disease impacting people in the United States and Europe.

930 Winter Street, Suite M-500
Waltham, MA, 02116
Industry Biotechnology
Employees 33

FAQs for Aerovate Therapeutics Inc Stock

No. AVTE does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

AVTE’s market cap is 615.13 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

AVTE’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare AVTE’s historical performance against its industry peers and the overall market.